NJ State Employees Deferred Compensation Plan - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,940
+80.1%
30,0000.0%0.00%0.0%
Q2 2023$4,965
-83.0%
30,0000.0%0.00%
-80.0%
Q1 2023$29,280
-6.2%
30,0000.0%0.01%0.0%
Q4 2022$31,200
-10.9%
30,0000.0%0.01%
-16.7%
Q3 2022$35,000
-37.5%
30,0000.0%0.01%
-33.3%
Q2 2022$56,000
-38.5%
30,0000.0%0.01%
-25.0%
Q1 2022$91,000
-19.5%
30,0000.0%0.01%
-14.3%
Q4 2021$113,000
-27.1%
30,0000.0%0.01%
-33.3%
Q3 2021$155,000
+34.8%
30,0000.0%0.02%
+40.0%
Q2 2021$115,000
+49.4%
30,0000.0%0.02%
+36.4%
Q1 2021$77,000
+2.7%
30,0000.0%0.01%
-8.3%
Q4 2020$75,000
+21.0%
30,0000.0%0.01%
+9.1%
Q3 2020$62,000
-33.3%
30,0000.0%0.01%
-35.3%
Q2 2020$93,000
+36.8%
30,0000.0%0.02%
+6.2%
Q1 2020$68,000
-37.6%
30,0000.0%0.02%
-15.8%
Q4 2019$109,000
+6.9%
30,0000.0%0.02%0.0%
Q3 2019$102,00030,0000.02%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders